Improving Solubility 2007

Venue: The Café Royal

Location: London, United Kingdom

Event Date/Time: Jun 26, 2007 End Date/Time: Jun 28, 2007
Early Registration Date: May 18, 2007
Report as Spam


Poorly soluble compounds represent roughly 60% of compounds in drug development, and this figure is only likely to increase. Pharma IQ’s 3rd annual Improving Solubility conference is an essential event for any scientist dealing with poorly soluble compounds, bringing together discovery chemistry and support, preformulation and formulation. Through practical case studies it will explore methods to predict and measure solubility, and strategies for solubility enhancement, including solid state and a range of formulation approaches. Through leading industry examples and in-depth discussion it will uncover best practices to help delegates increase the chances of development success for their poorly soluble compounds.


68 Regent Street
United Kingdom

Additional Information

Leab Sek, Senior Development Scientist, Formulation & Process Design, Merck Sharp & Dohme Shawn Yin, Senior Research Investigator, Bristol-Myers Squibb James Cunningham, Research Fellow, Pharmaceutical R&D, Merck & Co. Gary Eichenbaum, Principal Scientist / Project Leader, Global Preclinical Development, Johnson & Johnson PRD Li Di, Principal Scientist, Wyeth Research Paul Sutton, Fellow, Novartis Pharmaceuticals Rolf Brickl, Scientific Expert, Pharmaceutical R&D, Boehringer Ingelheim